| Financial Year |
March 31 2023 |
| Monetary Funds |
788,270,978.85 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,601,585.60 |
| Accounts Receivable |
845,481,759.45 |
| Advances to Suppliers |
174,118,002.76 |
| Other Receivables |
51,990,506.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
960.87 |
| Dividend Receivable |
-- |
| Inventories |
1,590,244,836.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,492,012.35 |
| Total Current Assets |
4,636,346,749.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
61,196,459.53 |
| Long-term Equity Investment |
-- |
| Investment Properties |
26,788,959.36 |
| Fixed Assetes |
221,705,455.58 |
| Under-construction Projects |
58,725.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,405,043.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
520,742.58 |
| Deferred Income Tax Assets |
43,094,887.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
371,770,273.71 |
| Total Assets |
5,008,117,023.59 |
| Short-Term Loans |
44,022,863.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
437,305,959.01 |
| Accounts Payable |
1,045,929,253.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
67,477,462.90 |
| Taxes Payable |
61,264,412.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,986,653.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
15,199,116.84 |
| Sub-Total of Current Liabilities |
3,436,542,951.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
57,485,569.61 |
| Deferred Income Tax Liabilities |
12,932.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,809,341.64 |
| Total Liabilities |
3,505,352,293.35 |
| Paid-In Capital(Or Share Stock) |
307,034,301.00 |
| Capital Surplus |
459,157,791.44 |
| Surplus Reserve |
73,247,840.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
663,392,497.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,502,764,730.24 |
| Owner's Equity（Stockholder's Equity） |
1,502,764,730.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,008,117,023.59 |
